Listen Top Shows Blog

Tackling the New Bottleneck of Drug Discovery

Tackling the New Bottleneck of Drug Discovery

Update: 2024-09-12

Share

Description

Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Biopharma Companies Wrestle with an Outsized Demand for AI Talent

Biopharma Companies Wrestle with an Outsized Demand for AI Talent

2024-11-1448:54

Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t

Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t

2024-10-2457:58

Unlocking Market Access with AI

Unlocking Market Access with AI

2024-10-1053:38

Ensuring Successful Implementation of AI

Ensuring Successful Implementation of AI

2024-10-0352:49

Tackling the New Bottleneck of Drug Discovery

Tackling the New Bottleneck of Drug Discovery

2024-09-1257:20

Swimming in the Deep End of AI

Swimming in the Deep End of AI

2024-08-2259:08

Using AI to Make Biology Easier to Engineer

Using AI to Make Biology Easier to Engineer

2024-07-2553:46

How AI ls Reshaping the Future of Healthcare

How AI ls Reshaping the Future of Healthcare

2024-06-2701:00:21

A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI

2024-06-1301:03:58

Decoding the Immune System to Optimize Immunotherapies

2024-05-3001:00:59

Bringing Precision Medicine to Mental Health with AI

2024-05-0958:21

The Power and Peril of Generative AI in Biopharma and Healthcare

The Power and Peril of Generative AI in Biopharma and Healthcare

2024-04-2552:25

Unlocking the Complexity of Disease with Transomics and AI

Unlocking the Complexity of Disease with Transomics and AI

2024-04-1147:10

Why Biopharma Companies Should Recognize Data Analytics and AI as Strategic Advantages

Why Biopharma Companies Should Recognize Data Analytics and AI as Strategic Advantages

2024-03-2851:46

Making Undruggable Targets a Thing of the Past

Making Undruggable Targets a Thing of the Past

2024-03-1449:44

Using AI to Revolutionize Precision Oncology

Using AI to Revolutionize Precision Oncology

2024-02-2242:18

Leveraging Data Analytics to Enhance Biopharma Sales

2024-01-3140:11

00:00

00:00

x

Tackling the New Bottleneck of Drug Discovery

Tackling the New Bottleneck of Drug Discovery

Levine Media Group